Poly Medicure Limited

NSEI:POLYMED Stock Report

Market Cap: ₹190.0b

Poly Medicure Past Earnings Performance

Past criteria checks 4/6

Poly Medicure has been growing earnings at an average annual rate of 23.4%, while the Medical Equipment industry saw earnings growing at 21% annually. Revenues have been growing at an average rate of 16.3% per year. Poly Medicure's return on equity is 17.6%, and it has net margins of 18.8%.

Key information

23.4%

Earnings growth rate

21.2%

EPS growth rate

Medical Equipment Industry Growth23.0%
Revenue growth rate16.3%
Return on equity17.6%
Net Margin18.8%
Last Earnings Update31 Mar 2024

Recent past performance updates

Poly Medicure's (NSE:POLYMED) Promising Earnings May Rest On Soft Foundations

May 25
Poly Medicure's (NSE:POLYMED) Promising Earnings May Rest On Soft Foundations

Recent updates

Poly Medicure's (NSE:POLYMED) Promising Earnings May Rest On Soft Foundations

May 25
Poly Medicure's (NSE:POLYMED) Promising Earnings May Rest On Soft Foundations

Why You Should Care About Poly Medicure's (NSE:POLYMED) Strong Returns On Capital

May 12
Why You Should Care About Poly Medicure's (NSE:POLYMED) Strong Returns On Capital

Poly Medicure Limited's (NSE:POLYMED) Share Price Not Quite Adding Up

Mar 23
Poly Medicure Limited's (NSE:POLYMED) Share Price Not Quite Adding Up

Here's Why We Think Poly Medicure (NSE:POLYMED) Might Deserve Your Attention Today

Feb 15
Here's Why We Think Poly Medicure (NSE:POLYMED) Might Deserve Your Attention Today

Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly

Jan 16
Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly

Is Now The Time To Put Poly Medicure (NSE:POLYMED) On Your Watchlist?

Nov 14
Is Now The Time To Put Poly Medicure (NSE:POLYMED) On Your Watchlist?

Poly Medicure (NSE:POLYMED) Has More To Do To Multiply In Value Going Forward

Oct 24
Poly Medicure (NSE:POLYMED) Has More To Do To Multiply In Value Going Forward

Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being

Sep 22
Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being

Poly Medicure (NSE:POLYMED) Is Increasing Its Dividend To ₹3.00

Sep 08
Poly Medicure (NSE:POLYMED) Is Increasing Its Dividend To ₹3.00

Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly

Aug 12
Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly

Here's Why We Think Poly Medicure (NSE:POLYMED) Is Well Worth Watching

Jul 13
Here's Why We Think Poly Medicure (NSE:POLYMED) Is Well Worth Watching

Poly Medicure (NSE:POLYMED) Is Reinvesting At Lower Rates Of Return

Jun 16
Poly Medicure (NSE:POLYMED) Is Reinvesting At Lower Rates Of Return

Be Wary Of Poly Medicure (NSE:POLYMED) And Its Returns On Capital

Mar 02
Be Wary Of Poly Medicure (NSE:POLYMED) And Its Returns On Capital

We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt

Feb 14
We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt

Capital Allocation Trends At Poly Medicure (NSE:POLYMED) Aren't Ideal

Oct 16
Capital Allocation Trends At Poly Medicure (NSE:POLYMED) Aren't Ideal

We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt

Sep 28
We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt

Poly Medicure (NSE:POLYMED) Has Affirmed Its Dividend Of ₹2.50

Sep 08
Poly Medicure (NSE:POLYMED) Has Affirmed Its Dividend Of ₹2.50

Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly

Jun 25
Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly

A Look At The Intrinsic Value Of Poly Medicure Limited (NSE:POLYMED)

Jun 07
A Look At The Intrinsic Value Of Poly Medicure Limited (NSE:POLYMED)

Poly Medicure (NSE:POLYMED) Will Want To Turn Around Its Return Trends

May 23
Poly Medicure (NSE:POLYMED) Will Want To Turn Around Its Return Trends

With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting

Feb 23
With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting

There Are Reasons To Feel Uneasy About Poly Medicure's (NSE:POLYMED) Returns On Capital

Feb 04
There Are Reasons To Feel Uneasy About Poly Medicure's (NSE:POLYMED) Returns On Capital

Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly

Jan 12
Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly

With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting

Oct 14
With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting

Poly Medicure (NSE:POLYMED) Could Easily Take On More Debt

Jul 07
Poly Medicure (NSE:POLYMED) Could Easily Take On More Debt

Poly Medicure (NSE:POLYMED) Will Will Want To Turn Around Its Return Trends

Jun 18
Poly Medicure (NSE:POLYMED) Will Will Want To Turn Around Its Return Trends

Poly Medicure's (NSE:POLYMED) Solid Profits Have Weak Fundamentals

May 31
Poly Medicure's (NSE:POLYMED) Solid Profits Have Weak Fundamentals

Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹1,195

May 26
Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹1,195

Shareholders of Poly Medicure (NSE:POLYMED) Must Be Delighted With Their 448% Total Return

Mar 01
Shareholders of Poly Medicure (NSE:POLYMED) Must Be Delighted With Their 448% Total Return

I Ran A Stock Scan For Earnings Growth And Poly Medicure (NSE:POLYMED) Passed With Ease

Feb 16
I Ran A Stock Scan For Earnings Growth And Poly Medicure (NSE:POLYMED) Passed With Ease

How Much Is Poly Medicure Limited (NSE:POLYMED) CEO Getting Paid?

Feb 01
How Much Is Poly Medicure Limited (NSE:POLYMED) CEO Getting Paid?

Did Poly Medicure Limited (NSE:POLYMED) Insiders Sell Shares?

Jan 17
Did Poly Medicure Limited (NSE:POLYMED) Insiders Sell Shares?

Poly Medicure Limited's (NSE:POLYMED) Stock Is Going Strong: Is the Market Following Fundamentals?

Dec 09
Poly Medicure Limited's (NSE:POLYMED) Stock Is Going Strong: Is the Market Following Fundamentals?

Announcing: Poly Medicure (NSE:POLYMED) Stock Increased An Energizing 205% In The Last Five Years

Nov 24
Announcing: Poly Medicure (NSE:POLYMED) Stock Increased An Energizing 205% In The Last Five Years

Is Poly Medicure (NSE:POLYMED) Using Too Much Debt?

Nov 09
Is Poly Medicure (NSE:POLYMED) Using Too Much Debt?

Many Would Be Jealous Of Poly Medicure's (NSE:POLYMED) Returns On Capital

Oct 26
Many Would Be Jealous Of Poly Medicure's (NSE:POLYMED) Returns On Capital

Have Insiders Been Selling Poly Medicure Limited (NSE:POLYMED) Shares?

Oct 06
Have Insiders Been Selling Poly Medicure Limited (NSE:POLYMED) Shares?

Should You Be Adding Poly Medicure (NSE:POLYMED) To Your Watchlist Today?

Sep 17
Should You Be Adding Poly Medicure (NSE:POLYMED) To Your Watchlist Today?

Should Poly Medicure Limited (NSE:POLYMED) Be Part Of Your Dividend Portfolio?

Sep 02
Should Poly Medicure Limited (NSE:POLYMED) Be Part Of Your Dividend Portfolio?

Revenue & Expenses Breakdown

How Poly Medicure makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NSEI:POLYMED Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 2413,7582,5832,459190
31 Dec 2313,0462,4872,349198
30 Sep 2312,4982,3372,278193
30 Jun 2311,8722,1502,151182
31 Mar 2311,1521,7932,076178
31 Dec 2210,6591,5661,979171
30 Sep 2210,1131,4111,866178
30 Jun 229,6001,3591,751188
31 Mar 229,2311,4651,671188
31 Dec 218,7851,4921,590174
30 Sep 218,5181,5001,544159
30 Jun 218,2801,4681,489140
31 Mar 217,8651,3591,448131
31 Dec 207,4481,1971,434129
30 Sep 207,2181,0941,409124
30 Jun 206,9601,0281,359121
31 Mar 206,8729591,431119
31 Dec 196,8819471,42797
30 Sep 196,6258581,37798
30 Jun 196,3887191,229100
31 Mar 196,1086541,224101
31 Mar 185,2047061,035100
31 Mar 174,55055193190
31 Mar 164,12348379187
31 Mar 153,90362368785
31 Mar 143,22245178459

Quality Earnings: POLYMED has a high level of non-cash earnings.

Growing Profit Margin: POLYMED's current net profit margins (18.8%) are higher than last year (16.1%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: POLYMED's earnings have grown significantly by 23.4% per year over the past 5 years.

Accelerating Growth: POLYMED's earnings growth over the past year (44.1%) exceeds its 5-year average (23.4% per year).

Earnings vs Industry: POLYMED earnings growth over the past year (44.1%) exceeded the Medical Equipment industry 23.2%.


Return on Equity

High ROE: POLYMED's Return on Equity (17.6%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.